Antisense therapeutics
By: edited by M. Ian Phillips ; foreword by Stanley T. Crooke.
Contributors: Phillips, M. Ian.
Edition: 2nd ed.
Series: Methods in molecular medicine -- 106
Publisher: Humana Press
Published: 2005
Place of publication: Totowa, N.J
Language: eng
Number of pages: 327
Subjects: Antisense nucleic acids -- Therapeutic use.; Oligonucleotides, Antisense -- therapeutic use.; Oligonucleotides, Antisense -- pharmacology.
Notes: Includes bibliographical references and index.
Table of contents: value: Antisense therapeutics: a promise waiting to be fulfilled / Ian Phillips; value: Antisense inhibition: oligonucleotides, ribozymes and siRNAs / Y. Clare Zhang ... [et al.]; value: Local application of antisense for prevention of restenosis / Patrick L. Iversen ... [et al.]; value: Antisense therapeutics for hypertension: targeting the renin/angiotensin system / M. Ian Phillips and Birgitta Kimura; value: Antisense strategies for the treatment of heart failure / Sian E. Harding, Federica Del Monte, and Roger J. Hajjar; value: Clinical studies of antisense oligonucleotides for cancer therapy / Rosanne M. Orr and F. Andrew Dorr; value: Antisense therapy in clinical oncology: preclinical and clinical experiences / Ingo Tamm; value: Radionucleide/peptide nucleic acid diagnosis and treatment of pancreatic cancer / Eric Wickstrom ... [et al.]; value: Suppression of pancreatic and colon cancer cells by antisense K-RNA expression vectors / Kazunori Aoki, Shumpei Ohnami, and Teruhiko Yoshida; value: Induction of tumor cell apoptosis and chemosensitization by antisense strategies / Manuel Rieber and Mary Strasberg-Rieber; value: Utility of an anti-oncogene ribozymes and antisense oligonucletoides in reversing drug resistance / Tadao Funato; value: Transport of antisense across the blood/brain barrier / Laura B. Jaeger and William A. Banks; value: Transdermal delivery of antisense oligonucletoides / Rhonda M. Brand and Patrick L. Iversen; value: Antisense strategies for redirection of drug metabolism: using paclitaxel as a model / Vikram Arora; value: Antisense oligonucletoide treatment of inflammatory bowel diseases / Bruce R. Yacyshyn; value: Optimizing electroporation conditions for the intracellular delivery of morpholino antisense oligonucleotides directed against the hepatitis C virus IRES / Ronald Jubin.